Publications in collaboration with researchers from Erasmus University Rotterdam (13)

2017

  1. Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal, Vol. 38, Núm. 42, pp. 3124-3134

2013

  1. The p53 codon 72 polymorphism (rs1042522) is associated with proliferative vitreoretinopathy: The retina 4 project

    Ophthalmology, Vol. 120, Núm. 3, pp. 623-628

2009

  1. Increasing Numbers of Most Mature Peripheral Blood B-Subsets are Observed in Monoclonal Gammopathies

    CLINICAL LYMPHOMA & MYELOMA

  2. The European Myeloma Stem Cell Network (MSCNET)

    CLINICAL LYMPHOMA & MYELOMA

2008

  1. Generation of flow cytometry data files waith a potentially infinite number of dimensions

    CELLULAR ONCOLOGY

2003

  1. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: Immunobiological characteristics and clinical implications

    Leukemia, Vol. 17, Núm. 7, pp. 1398-1403

2002

  1. Differentiation between normal and pathological plasma cells by four colour flow cytometry

    CYTOMETRY

2000

  1. BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

    Leukemia, Vol. 14, Núm. 5, pp. 816-825

1999

  1. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

    British Journal of Haematology, Vol. 104, Núm. 4, pp. 695-705

  2. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: Investigation of minimal residual disease in acute leukemia

    Leukemia, Vol. 13, Núm. 1, pp. 110-118

  3. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia

    Leukemia

1995

  1. Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): Clinical, cytogenetic and molecular studies

    Leukemia, Vol. 9, Núm. 7, pp. 1162-1166

1988

  1. Mapping studies and expression of genes located on human chromosome 11, band q23

    Cytogenetic and Genome Research, Vol. 49, Núm. 4, pp. 289-292